Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rituxan in the Management of Multiple Myeloma

NCT00003554 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT00003554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rituxan in the Management of Multiple Myeloma
Lead sponsor
The Cleveland Clinic
Phase
Phase 2
Overall status
Completed
Start date
November 30, 1998
Completion date
April 30, 2004
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma and plasma cell neoplasm